Skip to main content
Cuorips Inc. logo

Cuorips Inc. — Investor Relations & Filings

Ticker · 4894 ISIN · JP3266030000 T Manufacturing
Open in API
Filings indexed 27 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country JP Japan
Listing T 4894

About Cuorips Inc.

https://cuorips.co.jp/en/

Cuorips Inc. is a regenerative medicine company that originated as a spin-off from Osaka University. The company specializes in the research, development, and commercialization of cellular and tissue-based products derived from induced pluripotent stem (iPS) cells. Its primary product is a cardiac myocyte sheet, a novel therapy developed for treating severe heart failure. This cardiac tissue sheet, created from iPS cells, is designed to be grafted onto a patient's heart to restore function. In addition to its proprietary product pipeline, Cuorips provides contract services for the development and manufacturing of cell processing products, contributing to the advancement of medical care through cutting-edge technology.

Recent filings

Filing Released Lang Actions
臨時報告書
Regulatory Filings Classification · 85% confidence The document is a Japanese “臨時報告書” (Extraordinary Report) filed under the Financial Instruments and Exchange Act to disclose a change in the company’s accounting auditor. It is not an AGM presentation, earnings release, annual report, or management discussion. It is a regulatory disclosure of auditor appointment/retirement, fitting the fallback “Regulatory Filings” category (RNS).
2026-05-27 Japanese
会計監査人の異動に関するお知らせ
Regulatory Filings Classification · 75% confidence The document is a corporate notice announcing the appointment and resignation of the company’s external accounting auditor in accordance with the Financial Instruments and Exchange Act. It does not contain actual financial statements, earnings figures, or in-depth audit opinions, nor is it an AGM presentation or management change for executives. There is no dedicated category for auditor‐change announcements, so under the classification rules it falls into the general "Regulatory Filings" catch‐all category.
2026-05-26 Japanese
役員の異動に関するお知らせ
Board/Management Information Classification · 91% confidence The document is a formal announcement by Cuorips Co., Ltd. regarding the nomination, reappointment, and retirement of directors and statutory auditors following its Annual General Meeting. It lists candidates for board and audit positions and their resumes, clearly indicating changes in the company’s board structure. This matches the definition of Board/Management Information (MANG).
2026-05-26 Japanese
本店移転及び定款の一部変更に関するお知らせ
Regulatory Filings Classification · 85% confidence The document is a regulatory announcement by the board of Quolips Co., Ltd. regarding the relocation of the head office and associated partial amendment of the Articles of Incorporation to be proposed at the upcoming annual shareholders meeting. It does not contain financial statements, proxy materials in full, or executive management changes; it is a general compliance/corporate action disclosure. This best fits the "Regulatory Filings (RNS)" category.
2026-05-26 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. H1 2025
2025-11-13 Japanese
半期報告書－第10期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Cuorips Inc. with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, management analysis (MD&A), and corporate information for the interim period (April 1, 2025, to September 30, 2025). This fits the definition of an Interim/Quarterly Report (IR). H1 2026
2025-11-13 Japanese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.